Pharmacokinetics, Safety, and Monotherapy Antiviral Activity of GSK1265744, an HIV Integrase Strand Transfer Inhibitor
HIV Clinical Trials · 2013-10 · 14 (5) · 192-203
DOI: 10.1310/hct1405-192 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift HIV Clinical Trials, online erschienen am 22.12.2014. Verfasst von W Spreen und 8 weiteren Autor:innen. Beteiligte Einrichtung: GlaxoSmithKline, Research Triangle Park, North Carolina, USA. Die Arbeit wurde bisher 108-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
Zitieren
APA
Spreen, W., Min, S., Ford, S. L., Chen, S., Lou, Y., Bomar, M., St Clair, M., Piscitelli, S., & Fujiwara, T. (2013). Pharmacokinetics, Safety, and Monotherapy Antiviral Activity of GSK1265744, an HIV Integrase Strand Transfer Inhibitor. HIV Clinical Trials, 14(5), 192-203. https://doi.org/10.1310/hct1405-192
Vancouver
Spreen W, Min S, Ford SL, Chen S, Lou Y, Bomar M, et al. Pharmacokinetics, Safety, and Monotherapy Antiviral Activity of GSK1265744, an HIV Integrase Strand Transfer Inhibitor. HIV Clinical Trials. 2013;14(5):192-203. doi:10.1310/hct1405-192
BibTeX
@article{Spreen2013,
author = {Spreen, W and Min, S and Ford, S L and Chen, S and Lou, Y and Bomar, M and St Clair, M and Piscitelli, S and Fujiwara, T},
title = {Pharmacokinetics, Safety, and Monotherapy Antiviral Activity of GSK1265744, an HIV Integrase Strand Transfer Inhibitor},
journal = {HIV Clinical Trials},
year = {2013},
volume = {14},
number = {5},
pages = {192--203},
doi = {10.1310/hct1405-192}
}
EUVIMED